| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/12/2000 | EP0991638A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 04/12/2000 | EP0991630A1 Crystalline roxifiban |
| 04/12/2000 | EP0991628A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56?lck TYROSINE KINASES |
| 04/12/2000 | EP0991627A1 Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/12/2000 | EP0991626A2 Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds |
| 04/12/2000 | EP0991618A1 Selective thyroid hormone analogs |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250376A Treatment of infarcts through inhibition of NF-KAPPAB |
| 04/12/2000 | CN1250051A New indane-1-alcohol compound, its preparation method and medical composition containing the same |
| 04/12/2000 | CN1249943A Preparation process of compound red sage tablet |
| 04/12/2000 | CN1051313C 5-arylindole derivatives and its use, pharmaceutical composition containing the same and intermediate for preparing them |
| 04/12/2000 | CN1051312C Thiazolidine derivatives and its pharmaceutical useage |
| 04/12/2000 | CN1051311C N-heteroaryl-n'-phenylurea derivatives, their production and use |
| 04/12/2000 | CN1051302C 3-(indol-3-yL) propenoic acid derivatives and as NMDA antagonists |
| 04/12/2000 | CN1051239C Antihypertensive health bathing vinegar |
| 04/11/2000 | US6048897 Lipoxin compounds and their use in treating cell proliferative disorders |
| 04/11/2000 | US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders |
| 04/11/2000 | US6048889 Proline derivatives |
| 04/11/2000 | US6048883 Hypoglycemic agent |
| 04/11/2000 | US6048880 Therapy for cytokine sensitive diseases |
| 04/11/2000 | US6048879 Dietetics |
| 04/11/2000 | US6048874 Parenteral metolazone formulations |
| 04/11/2000 | US6048873 Skin disorders |
| 04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
| 04/11/2000 | US6048853 Psychological disorders; nervous system disorders |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
| 04/11/2000 | US6048534 Methods and compositions for the selective regulation of chorionic prostanoids |
| 04/11/2000 | US6048523 Polyester cyclic compounds, their complexes and bonded bodies |
| 04/11/2000 | CA2030346C Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds |
| 04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA2011617C 4g.alpha.d-glucopyranosyl rutin, and its preparation and uses |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | WO2000018899A2 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | WO2000018804A1 Tie2 agonist antibodies |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | WO2000018764A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | WO2000018758A1 Pyrimidone derivatives |
| 04/06/2000 | WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors |
| 04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
| 04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 04/06/2000 | WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 04/06/2000 | WO2000018421A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | WO2000018398A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | WO2000018395A1 Method for preventing or delaying catheter-based revascularization |
| 04/06/2000 | WO2000018375A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000018336A1 Targeted therapy to a biomedical device |
| 04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | WO1999064585A3 Novel angiotensin receptor, production and use thereof |
| 04/06/2000 | WO1999062505A3 Method for treating neurodegenerative disorders |
| 04/06/2000 | WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases |
| 04/06/2000 | DE19845153A1 Imidazo[4,5]-pyridin-4-on-derivate Imidazo [4,5] pyridin-4-one derivatives |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | CA2345273A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/06/2000 | CA2345065A1 Pyrimidone derivatives |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344274A1 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | CA2343716A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0990024A1 USE OF $i(LACTOBACILLUS) FOR REDUCTION OF THE FIBRINOGEN LEVEL IN BLOOD |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/05/2000 | EP0989986A1 5,7-disubstituted 4-aminopyrido 2,3-d]pyrimidine compounds and their use as adenosine kinase inhibitors |
| 04/05/2000 | EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989972A1 Prostaglandin pharmaceutical compositions |
| 04/05/2000 | EP0989852A1 Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0765308B1 Enzyme inhibitors |
| 04/05/2000 | EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 04/05/2000 | CN1249748A Small molecules useful in treatment of inflamatory disease |
| 04/05/2000 | CN1249745A Vitronectin receptor antagonists |
| 04/05/2000 | CN1249682A Use of angiotension II antagonists to treat symptomatic heart failure |
| 04/05/2000 | CN1051086C Heterocycle-condensed morphinoid derivs. and use thereof |
| 04/05/2000 | CN1051085C Substed. dihydropyranopyridines, their preparation process, use and pharmaceutical composition contg. same |
| 04/05/2000 | CN1051081C Method for preparing inclusion complexes of 3-morpholino-sydnonimine |
| 04/05/2000 | CN1051080C Method for preparing pharmaceutical composition contg. substd. sydnonimine or salts |
| 04/05/2000 | CN1051019C Stasis eliminating and pulse-beat invigorating capsule |
| 04/05/2000 | CN1051017C Thrombus dissolving 'Guiluchun' |